Cargando…
Carcinoid syndrome: update on the pathophysiology and treatment
Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcinoid syndrome, which is a paraneoplastic syndrome associated with the secretion of several humoral factors. Carcinoid syndrome significantly and negatively affects patients' quality of life; increa...
Autores principales: | de Celis Ferrari, Anezka C. Rubin, Glasberg, João, Riechelmann, Rachel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096975/ https://www.ncbi.nlm.nih.gov/pubmed/30133565 http://dx.doi.org/10.6061/clinics/2018/e490s |
Ejemplares similares
-
Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome
por: Clement, Dominique, et al.
Publicado: (2020) -
Complications from carcinoid syndrome: review of the current evidence
por: Mota, José Mauricio, et al.
Publicado: (2016) -
European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
por: Grozinsky‐Glasberg, Simona, et al.
Publicado: (2022) -
Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
por: Hofland, Johannes, et al.
Publicado: (2021) -
An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome
por: Raina, Rupesh, et al.
Publicado: (2020)